Skip to main content

Table 1 Medicines with >20 newspaper articles (July 2005-June 2008)

From: Medicines and the media: news reports of medicines recommended for government reimbursement in Australia

Generic name, brand name (Indication for PBS listing)

No. of articles

Number of articles located

  

Articles in 6 months prior

Articles in PBAC meeting month

Articles 6 months post

HPV vaccine

1230

484

215

409

(NIP)

Trastuzumab †

410

113

32

104

(Breast cancer)

Pemetrexed †

83

20

39

16

(Mesothelioma)

Botulinum toxin

71

11

1

26

(Spasticity)

Lapatinib †

65

14

4

21

(Breast cancer)

Methylphenidate

57

12

3

27

(ADHD)

Atomoxetine

54

6

4

25

(ADHD)

Tdap vaccine

53

9

4

20

(NIP)

Infliximab †

49

12

3

32

(Crohn disease, psoriatic arthritis)

Rotavirus vaccine

45

13

5

16

(NIP)

Varenicline

39

1

1

24

(Smoking cessation)

Docetaxel †

36

3

4

17

(Breast cancer, prostate cancer)

Fentanyl

30

6

4

8

(Severe pain)

Sildenafil †

28

5

0

0

(Pulmonary hypertension)

Paclitaxel

27

3

3

11

(Breast cancer)

Imatinib †

26

2

0

6

(Acute lymphoblastic leukaemia)

Ranibizumab †

26

4

2

9

(Macular degeneration)

Natalizumab †

21

2

0

 

(Multiple sclerosis)

Total

2350

720

324

783

  1. Abbreviations: NIP, National immunisation program; ADHD, Attention-deficient hyperactivity disorder; HPV, Human papillomavirus; Tdap, Tetanus, diphtheria, acellular pertussis.
  2. † Cost more than AUD$10,000 per year or course of treatment.